Biotech News
Related news
HYPRHyperfine2026-07-23 20:05 EST
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
PAVMPAVmed2026-08-14 12:00 EST
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
SMTISanara MedTech2026-08-11 20:10 EST
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
STXSStereotaxis2026-08-11 20:01 EST
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
STIMNeuronetics2026-08-11 11:50 EST
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
TMCITreace Medical Concepts2026-08-07 11:05 EST
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
CVRXCVRx2026-08-06 20:05 EST
CVRx Reports Second Quarter 2026 Financial and Operating Results
PLSEPulse Biosciences2026-08-06 20:05 EST
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
Hyperfine
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...
Recent company news
HYPRHyperfine2026-09-15 12:15 EST
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
HYPRHyperfine2026-08-31 12:15 EST
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
HYPRHyperfine2026-08-26 12:15 EST
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
HYPRHyperfine2026-08-20 12:15 EST
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
HYPRHyperfine2026-08-06 20:05 EST
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Stock data
- Close
- 0.78 USD
- Market cap
- 148.91M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States